Han Ming Ho, partner at Sidley Austin in Singapore and co-head of its Asia Investment Funds practice, talks about what concerns the industry most, from a regulatory perspective. “Singapore regulations on the requirement to report OTC derivative trades have recently been issued. This reporting mandate is being implemented in phases and phase one covers reporting of interest rate and credit derivatives…
To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
Subscriber Only Content
This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.
Need help? Please see our FAQ Guide or email [email protected]